Tobacco.org

People in Clinical Trials May Live Longer 

People with lung cancer who take part in clinical trials live longer than those who receive standard cancer treatment, reports new research.

The study offers the first evidence that clinical trials offer cost-effective treatment -- costing only slightly more than standard treatment -- for people with non-small lung cancer. The finding appears in the Oct. 1 issue of the journal Cancer.

Researchers at the Center for Cancer Economics, Technology Assessment, Innovation and Development in Detroit compared the outcomes for people with non-small cell lung cancer taking part in clinical trials with the outcomes of those receiving standard therapy. They also evaluated the cost-effectiveness of each treatment. . . .

SOURCE: John Wiley & Sons Inc., news release, Aug. 25, 2003

Jump to full article »